200 related articles for article (PubMed ID: 32248600)
21. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
[TBL] [Abstract][Full Text] [Related]
23. Expression of snail, twist, and Zeb1 in malignant mesothelioma.
Merikallio H; Pääkkö P; Salmenkivi K; Kinnula V; Harju T; Soini Y
APMIS; 2013 Jan; 121(1):1-10. PubMed ID: 23030626
[TBL] [Abstract][Full Text] [Related]
24. Global overexpression of divalent metal transporter 1 delays crocidolite-induced mesothelial carcinogenesis in male mice.
Funahashi S; Okazaki Y; Nishiyama T; Ohyoshi H; Yasui H; Nishida K; Matsui S; Toyokuni S
Free Radic Res; 2018 Sep; 52(9):1030-1039. PubMed ID: 30309285
[TBL] [Abstract][Full Text] [Related]
25. CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells.
Komiya E; Ohnuma K; Yamazaki H; Hatano R; Iwata S; Okamoto T; Dang NH; Yamada T; Morimoto C
Biochem Biophys Res Commun; 2014 May; 447(4):609-15. PubMed ID: 24747072
[TBL] [Abstract][Full Text] [Related]
26. Ferruginous bodies resolved by synchrotron XRF in a dog with peritoneal malignant mesothelioma.
Pascotto E; Gianoncelli A; Calligaro C; Marcuzzo T; Melato M; Rizzardi C; Pascolo L
Environ Sci Pollut Res Int; 2018 Dec; 25(35):35707-35714. PubMed ID: 30357666
[TBL] [Abstract][Full Text] [Related]
27. Dual preventive benefits of iron elimination by desferal in asbestos-induced mesothelial carcinogenesis.
Jiang L; Chew SH; Nakamura K; Ohara Y; Akatsuka S; Toyokuni S
Cancer Sci; 2016 Jul; 107(7):908-15. PubMed ID: 27088640
[TBL] [Abstract][Full Text] [Related]
28. Connective tissue growth factor and β-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma.
Jiang L; Yamashita Y; Chew SH; Akatsuka S; Ukai S; Wang S; Nagai H; Okazaki Y; Takahashi T; Toyokuni S
J Pathol; 2014 Aug; 233(4):402-14. PubMed ID: 24839947
[TBL] [Abstract][Full Text] [Related]
29. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
[TBL] [Abstract][Full Text] [Related]
30. Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells.
Kim MC; Cui FJ; Kim Y
Asian Pac J Cancer Prev; 2013; 14(6):3625-30. PubMed ID: 23886156
[TBL] [Abstract][Full Text] [Related]
31. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
Cheng YY; Wright CM; Kirschner MB; Williams M; Sarun KH; Sytnyk V; Leshchynska I; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; van Zandwijk N; Lin RC; Reid G
Mol Cancer; 2016 Jun; 15(1):44. PubMed ID: 27245839
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.
El Bezawy R; De Cesare M; Pennati M; Deraco M; Gandellini P; Zuco V; Zaffaroni N
J Hematol Oncol; 2017 Jan; 10(1):19. PubMed ID: 28100259
[TBL] [Abstract][Full Text] [Related]
33. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
34. Gene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathways.
Blackshear PE; Pandiri AR; Nagai H; Bhusari S; Hong HH; Ton TV; Clayton NP; Wyde M; Shockley KR; Peddada SD; Gerrish KE; Sills RC; Hoenerhoff MJ
Toxicol Pathol; 2015 Feb; 43(2):171-85. PubMed ID: 24958746
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of miR-222 and miR-126 regulation and its role in asbestos-induced malignancy.
Gaetani S; Monaco F; Alessandrini F; Tagliabracci A; Sabbatini A; Bracci M; Valentino M; Neuzil J; Amati M; Santarelli L; Tomasetti M
Int J Biochem Cell Biol; 2020 Apr; 121():105700. PubMed ID: 32006662
[TBL] [Abstract][Full Text] [Related]
36. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
[TBL] [Abstract][Full Text] [Related]
37. CD146 and insulin-like growth factor 2 mRNA-binding protein 3 predict prognosis of asbestos-induced rat mesothelioma.
Okazaki Y; Nagai H; Chew SH; Li J; Funahashi S; Tsujimura T; Toyokuni S
Cancer Sci; 2013 Aug; 104(8):989-95. PubMed ID: 23621518
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.
Borczuk AC; Pei J; Taub RN; Levy B; Nahum O; Chen J; Chen K; Testa JR
Cancer Biol Ther; 2016; 17(3):328-35. PubMed ID: 26853494
[TBL] [Abstract][Full Text] [Related]
39. Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.
Chirac P; Maillet D; Leprêtre F; Isaac S; Glehen O; Figeac M; Villeneuve L; Péron J; Gibson F; Galateau-Sallé F; Gilly FN; Brevet M
Hum Pathol; 2016 Sep; 55():72-82. PubMed ID: 27184482
[TBL] [Abstract][Full Text] [Related]
40. Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats.
Ohara Y; Chew SH; Shibata T; Okazaki Y; Yamashita K; Toyokuni S
Cancer Sci; 2018 Feb; 109(2):330-339. PubMed ID: 29193587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
